These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8895666)

  • 21. Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy.
    Ito T; Kaneko K; Makino R; Ito H; Konishi K; Kurahashi T; Kitahara T; Mitamura K
    J Gastroenterol; 2001 May; 36(5):303-11. PubMed ID: 11388392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma.
    Khurshid A; Kazuya N; Hanae I; Manabu I
    J Pak Med Assoc; 1998 May; 48(5):138-42. PubMed ID: 9813975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
    Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
    J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
    Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
    J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa.
    Astori G; Merluzzi S; Arzese A; Brosolo P; de Pretis G; Maieron R; Pipan C; Botta GA
    Digestion; 2001; 64(1):9-14. PubMed ID: 11549832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of p53 mutations by single-strand conformation polymorphisms (SSCP) gel electrophoresis. A comparative study of radioactive and nonradioactive silver-stained SSCP analysis.
    Bosari S; Marchetti A; Buttitta F; Graziani D; Borsani G; Loda M; Bevilacqua G; Coggi G
    Diagn Mol Pathol; 1995 Dec; 4(4):249-55. PubMed ID: 8634780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China.
    Wang LD; Zhou Q; Hong JY; Qiu SL; Yang CS
    Cancer; 1996 Apr; 77(7):1244-9. PubMed ID: 8608498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 gene mutation in 150 dissected lymph nodes in a patient with esophageal cancer.
    Kajiyama Y; Kanno H; Ueno M; Udagawa H; Tsutsumi K; Kinoshita Y; Nakamura T; Akiyama H; Miwa S; Tsurumaru M
    Dis Esophagus; 1998 Oct; 11(4):279-83. PubMed ID: 10071815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia.
    Ireland AP; Shibata DK; Chandrasoma P; Lord RV; Peters JH; DeMeester TR
    Ann Surg; 2000 Feb; 231(2):179-87. PubMed ID: 10674608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
    Soslow RA; Altorki NK; Yang G; Xie D; Yang CS
    Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma.
    Ribeiro U; Finkelstein SD; Safatle-Ribeiro AV; Landreneau RJ; Clarke MR; Bakker A; Swalsky PA; Gooding WE; Posner MC
    Cancer; 1998 Jul; 83(1):7-18. PubMed ID: 9655287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.
    Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M
    Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine.
    Wang D; Weghorst CM; Calvert RJ; Stoner GD
    Carcinogenesis; 1996 Apr; 17(4):625-30. PubMed ID: 8625469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routine analysis of p53 mutation in clinical breast tumor specimens using fluorescence-based polymerase chain reaction and single strand conformation polymorphism.
    Iacopetta B; Elsaleh H; Grieu F; Joseph D; Sterrett G; Robbins P
    Diagn Mol Pathol; 2000 Mar; 9(1):20-5. PubMed ID: 10718209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mutations of p53 gene exons 5 to 8 in human ovarian cancer and its clinical significance].
    You Z; Guo Y; Wen H
    Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):660-3. PubMed ID: 9387525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 null mutations detected by a p53 yeast functional assay predict a poor outcome in young esophageal carcinoma patients.
    Osugi H; Morimura K; Okuda E; Takemura M; Higashino M; Takada N; Kinoshita H
    Int J Oncol; 2002 Sep; 21(3):637-41. PubMed ID: 12168111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.